Pacmilimab
Pacmilimab (CX-072) is a potent PD-L1 inhibitor. Pacmilimab shows antitumor activity[1].
Product Specifications
CAS Number
2145091-51-4
Product Name Alternative
CX-072
UNSPSC
12352203
Target
PD-1/PD-L1
Type
Inhibitory Antibodies
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/pacmilimab.html
Purity
95.00
Solubility
H2O
Smiles
[Pacmilimab]
Molecular Weight
(152.6 kDa)
References & Citations
[1]Naing A, et al. CX-072 (pacmilimab), a Probody ® PD-L1 inhibitor, in advanced or recurrent solid tumors (PROCLAIM-CX-072) : an open-label dose-finding and first-in-human study. J Immunother Cancer. 2021 Jul;9 (7) :e002447.
Shipping Conditions
Dry Ice
Storage Conditions
Store at -80°C for 2 years
Scientific Category
Inhibitory Antibodies
Clinical Information
Phase 2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
LV643023 1.0 µg DNA
RGD1564599 Lentiviral Vector (Rat) (CMV) (pLenti-GIII-CMV-GFP-2A-Puro)
Sign In for Pricing
View Details 